Table 2.

Descriptive Information and Primary Diagnosis Status at Pretreatment, Posttreatment, and Follow-up

Assessment	Variable	Treatment condition
		TAU	PCT	UP
Pre	Sample Size, n	11	13	13
	Age, M (SD)	51.04 (12.65)	48.08 (13.08)	42.08 (14.72)
	Gender, n (%)
	Female	0 (0.0)	2 (15.4)	5 (38.5)
	Male	11 (100.0)	11 (84.6)	8 (61.5)
	Race, n (%)
	Asian	0 (00)	0 (0.0)	1 (7.7)
	Black	5 (45.5)	3 (23.1)	1 (7.7)
	White	6 (54.5)	10 (76.9)	11 (84.6)
	Ethnicity, n (%)
	Hispanic/Latino	1 (9.1)	0 (0.0)	2 (15.4)
	Non-Hispanic/Latino	7 (63.6)	10 (76.9)	8 (61.5)
	Unknown	3 (27.3)	3 (23.1)	3 (23.1)
	Number of traumas	14.27 (5.89)	16.77 (6.58)	19.54 (9.16)
Post	Sample Size, n	11	11	13
	Primary dx, n (%)
	CSR < 4	4 (36.4)	5 (45.5)	7 (46.2)
	CSR >= 4	7 (63.6)	6 (54.5)	6 (53.8)
3MFU	Sample Size, n	11	11	13
	Primary dx, n (%)
	CSR < 4	4 (36.4)	5 (45.5)	6 (53.8)
	CSR >= 4	7 (63.6)	6 (54.5)	7 (46.2)

Note: TAU = Treatment as Usual, PCT = Present Centered Therapy, UP = Unified Protocol, Pre = pretreatment assessment, Post = posttreatment assessment, 3MFU = 3 month follow-up assessment, CSR = Clinical Severity Rating, n = sample size per condition, M = Mean, SD = Standard Deviation.